Koh KK, et al. Circulation. 2004

More documents

Recommendations

Info

혈관연구회 창립 심포지움, 3월 3일, 2005 Novel Markers of Arterial Dysfunction Kwang Kon Koh, MD, FACC, FAHA Cardiology Gachon Medical School Incheon, Korea
Atherosclerosis: A progressive process PHASE I: Initiation PHASE II: Progression PHASE III: Complication Disease progression
Page 4 and 5: Nitric Oxide • Regulates vasomoto
Page 7: Reactive Hyperemia
Page 10 and 11: 40 Subjects with a Parental History
Page 12 and 13: Kaplan-Meier Analysis of Patients w
Page 14 and 15: Cytokines LDL ox Ang II LPS CMV NAD
Page 16 and 17: Association Between MCP-1 Levels an
Page 18 and 19: Top, Rapid angiographic stenosis pr
Page 20 and 21: Therapeutic Intervention Cytokines
Page 22 and 23: Effects of Fenofibrate on Inflammat
Page 24 and 25: Combined therapy or fenofibrate alo
Page 26 and 27: Ramipril Combined with Simvastatin
Page 28 and 29: Additive Beneficial Effects of Rami
Page 30 and 31: Effects of Simvastatin, Combined Th
Page 32 and 33: ThankQ!
Page 34 and 35: Fenofibrate • Peroxisome Prolifer
Page 36 and 37: Fenofibrate suppresses inflammatory
Page 38 and 39: 10 Effects of Fenofibrate on Vasomo
Page 40 and 41: % Change in MDA Levels (%) Effects
Page 42: Combined Therapy Significantly Redu

Koh KK, et al. Circulation. 2004

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?